Correlation Between Spirent Communications and SCANDMEDICAL SOLDK

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Spirent Communications and SCANDMEDICAL SOLDK at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Spirent Communications and SCANDMEDICAL SOLDK into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Spirent Communications plc and SCANDMEDICAL SOLDK 040, you can compare the effects of market volatilities on Spirent Communications and SCANDMEDICAL SOLDK and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Spirent Communications with a short position of SCANDMEDICAL SOLDK. Check out your portfolio center. Please also check ongoing floating volatility patterns of Spirent Communications and SCANDMEDICAL SOLDK.

Diversification Opportunities for Spirent Communications and SCANDMEDICAL SOLDK

-0.46
  Correlation Coefficient

Very good diversification

The 3 months correlation between Spirent and SCANDMEDICAL is -0.46. Overlapping area represents the amount of risk that can be diversified away by holding Spirent Communications plc and SCANDMEDICAL SOLDK 040 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SCANDMEDICAL SOLDK 040 and Spirent Communications is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Spirent Communications plc are associated (or correlated) with SCANDMEDICAL SOLDK. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SCANDMEDICAL SOLDK 040 has no effect on the direction of Spirent Communications i.e., Spirent Communications and SCANDMEDICAL SOLDK go up and down completely randomly.

Pair Corralation between Spirent Communications and SCANDMEDICAL SOLDK

Assuming the 90 days horizon Spirent Communications plc is expected to generate 0.87 times more return on investment than SCANDMEDICAL SOLDK. However, Spirent Communications plc is 1.15 times less risky than SCANDMEDICAL SOLDK. It trades about 0.21 of its potential returns per unit of risk. SCANDMEDICAL SOLDK 040 is currently generating about -0.52 per unit of risk. If you would invest  206.00  in Spirent Communications plc on September 22, 2024 and sell it today you would earn a total of  10.00  from holding Spirent Communications plc or generate 4.85% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Spirent Communications plc  vs.  SCANDMEDICAL SOLDK 040

 Performance 
       Timeline  
Spirent Communications 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Spirent Communications plc are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, Spirent Communications may actually be approaching a critical reversion point that can send shares even higher in January 2025.
SCANDMEDICAL SOLDK 040 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days SCANDMEDICAL SOLDK 040 has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Spirent Communications and SCANDMEDICAL SOLDK Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Spirent Communications and SCANDMEDICAL SOLDK

The main advantage of trading using opposite Spirent Communications and SCANDMEDICAL SOLDK positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Spirent Communications position performs unexpectedly, SCANDMEDICAL SOLDK can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SCANDMEDICAL SOLDK will offset losses from the drop in SCANDMEDICAL SOLDK's long position.
The idea behind Spirent Communications plc and SCANDMEDICAL SOLDK 040 pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.

Other Complementary Tools

Global Correlations
Find global opportunities by holding instruments from different markets
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments